COST Analyst Ratings

Mizuho upgraded Costco to Outperform ($1000) in early January, a strong endorsement. Roth Capital went contrarian with a Sell ($769) in December. Consensus is Buy at $137 average target — premium valuation keeps bears vocal but members keep spending.

ANALYST RATINGS
Hold$984
COST
Outperform$1000
Upgrade
2026-01-05
Sell$769
Downgrade
2025-12-15
Outperform$1050
Reiterated
2025-11-03
Buy$1115
Initiated
2025-10-15
Neutral$975
Initiated
2025-04-11
Upgrade
2026-01-05
Mizuho
RatingOutperform
FromNeutral
Target$1000
From—
Downgrade
2025-12-15
Roth Capital
RatingSell
FromNeutral
Target$769
From—
Reiterated
2025-11-03
Oppenheimer
RatingOutperform
From—
Target$1050
From$1130
Initiated
2025-10-15
BTIG Research
RatingBuy
From—
Target$1115
From—
Initiated
2025-04-11
Mizuho
RatingNeutral
From—
Target$975
From—
Reiterated
2024-12-05
Telsey Advisory Group
RatingOutperform
From—
Target$1050
From$1000
Initiated
2024-10-22
Bernstein
RatingOutperform
From—
Target$1016
From—
Reiterated
2024-10-10
Oppenheimer
RatingOutperform
From—
Target$980
From$955
Reiterated
2024-09-27
Telsey Advisory Group
RatingOutperform
From—
Target$1000
From$925
Downgrade
2024-09-24
Truist
RatingHold
FromBuy
Target$873
From—
Downgrade
2024-09-10
Redburn Atlantic
RatingNeutral
FromBuy
Target$890
From$860
Reiterated
2024-09-09
Morgan Stanley
RatingOverweight
From—
Target$950
From$855
Upgrade
2024-08-08
Gordon Haskett
RatingBuy
FromAccumulate
Target$925
From—
Reiterated
2024-07-11
Telsey Advisory Group
RatingOutperform
From—
Target$925
From$900
Reiterated
2024-07-11
Oppenheimer
RatingOutperform
From—
Target$950
From$905
Reiterated
2024-07-02
Stifel
RatingBuy
From—
Target$900
From$850